Abstract
The avidity of TCRs for peptide-major histocompatibility complexes (pMHCs) is a governing factor in how T cells respond to antigen. TCR avidity is generally linked to T-cell functionality and there is growing evidence for distinct roles of low and high avidity T cells in different phases of immune responses. While physiological immune responses and many therapeutic T-cell products targeting infections or cancers consist of polyclonal T-cell populations with a wide range of individual avidities, the role of T-cell avidity is usually investigated only in monoclonal experimental settings. In this report, we induced polyclonal T-cell responses with a wide range of avidities toward a model epitope by altered peptide ligands, and benchmarked global avidity of physiological polyclonal populations by investigation of TCR-pMHC koff-rates. We then investigated how varying sizes and avidities of monoclonal subpopulations translate into global koff-rates. Global koff-rates integrate subclonal avidities in a predictably weighted manner and robustly correlate with the functionality of murine polyclonal T-cell populations in vitro and in vivo. Surveying the full avidity spectrum is essential to accurately assess polyclonal immune responses and inform the design of polyclonal T-cell therapeutics.
Author supplied keywords
Cite
CITATION STYLE
Lückemeier, P., Molter, K. L., Jarosch, S., Huppertz, P., Purcarea, A., Effenberger, M. J. P., … Busch, D. H. (2022). Global koff-rates of polyclonal T-cell populations merge subclonal avidities and predict functionality. European Journal of Immunology, 52(4), 582–596. https://doi.org/10.1002/eji.202149597
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.